Benjamin Galper
@BGalperMD
Followers
959
Following
6K
Media
90
Statuses
810
Director Structural Heart Program -MAPMG/VHC. Co-Director Cath Lab - VHC. Interests - interventional cardiology, clinical research, health policy. Tweets my own
Potomac, MD
Joined June 2015
The amazing story of our first Mitraclip patient @MdAtlPermanente His “heart spoke to him” after Mitraclip and he went from being unable to walk 100ft because of heart failure to proposing to his girlfriend 2 days later. An honor and privilege to treat our incredible patients.
At 84, Bob’s energetic lifestyle was halted by a leaky heart valve that left him unable to do the things he loved. See how MAPMG doctors helped him get back to an active life (so he could propose to his girlfriend) with an innovative #MitraClip procedure:
1
1
30
Congrats @MdAtlPermanente @LifeAtVHCHealth on completing our 1,000th TAVR. Honored to work w such an incredible, collaborative, and efficient team to save and improve so many lives. I’m so proud of what we’ve built together. @ameykulkarnimd @NoahHaroian @KPMidAtlantic @TAVRBot
1
3
15
Welcome to @MdAtlPermanente @NoahHaroian Rajeev Samtani. Excited for you to join our cardiology group and I can’t imagine better new partners for our structural heart team. No better first day than TAVR Tuesday! @GilbertTangMD @ameykulkarnimd @TAVRBot @johnkforrest @anvoramd
2
1
33
Honored to be involved in this incredible study demonstrating that next day discharge after TAVR is not only safe but may lead to decreased readmission and mortality. Thx @_WayneBatchelor for including me in this great project. @KendraGrubb @caresans26 @TAVRBot
So interesting to follow the phenomenal progress of transcatheter aortic valve replacement (TAVR)! Now quite routine for next day discharge (NDD). We published in JAHA that NDD appears to be safe and associated with favorable outcomes and low readmission rates within 1 year after
0
1
10
🄽🄴🅆 🅈🄾🅁🄺 🅅🄰🄻🅅🄴🅂 🗓️JUNE 5-7, 2024 📍JACOB K. JAVITS CONVENTION CENTER 🔗Early bird registration: https://t.co/k7k5DxhmIT 🎓Fellows free registration #NYValves2024
@sbrugaletta @adityadoc1 @AlkashkariWail @mathur_a @tavrkapadia @Hragy @nickaram @colum_owens
🌟 The future of valvular and structural heart disease is at #NYValves2024! Join us as we redefine innovation and multidisciplinary collaboration in structural heart care. 🫀💡 Take advantage of early-bird pricing! Rates go up on April 4. https://t.co/R8924OfpQW
#CardioTwitter
0
14
36
🌟 The future of valvular and structural heart disease is at #NYValves2024! Join us as we redefine innovation and multidisciplinary collaboration in structural heart care. 🫀💡 Take advantage of early-bird pricing! Rates go up on April 4. https://t.co/R8924OfpQW
#CardioTwitter
0
14
21
Honored to raise awareness of heart disease in women alongside Tookie our incredible TAVR patient. @MdAtlPermanente we diagnose and treat heart disease efficiently so our patients get back to activities quickly and live longer. @KPMidAtlantic #HeartMonth
https://t.co/cjD5xgyPLa
cbsnews.com
Many don’t know that heart disease is the number one killer of women in the United States. Understanding cardiac symptoms can be a lifesaver, especially given that women's symptoms often differ from...
0
2
16
Heart disease is the #1 killer of women in the U.S. — but symptoms present differently in women than they do in men. @BGalperMD and his patient Tookie Gentilcore spoke with @WJZ about what women should know.
cbsnews.com
Many don’t know that heart disease is the number one killer of women in the United States. Understanding cardiac symptoms can be a lifesaver, especially given that women's symptoms often differ from...
0
2
2
TAVR procedures are likely to become the gold standard of care for patients with severe aortic stenosis, but TAVR is not being disseminated as widely as it should be. But why? @BGalperMD's new research seeks to answer that question: https://t.co/32tDXQt3mP
0
1
1
Excited to present results of our TAVR Delay study today at 11am @TCTConference Lots of work to do to ensure all eligible patients receive TAVR. @MdAtlPermanente is poised to take on the challenge. @berrynat02 Honored our work featured in @CathLabDigest
0
2
12
12:30pm today in iCoach theater don’t miss an incredible panel on reasons for and consequences of delays in referral to TAVR. We will be tackling why only 50% of patients with severe AS get referred for life saving TAVR procedures. Join us room 203 @TCTConference @EdwardsLifesci
0
0
7
The story of a complex BASILICA TAVR patient who went on to win the gold medal in pickle ball at the senior Olympics. Honored to work with an incredible team to give life back to amazing patients. @MdAtlPermanente @KPMidAtlantic @LifeAtVHCHealth @TAVRBot
0
2
10
Surprise cake today after our 800th TAVR. Thx Megan best coordinator ever! Proud to work with an incredible team to help so many amazing patients. The force is strong in our program. @MdAtlPermanente @LifeAtVHCHealth Happy TAVR 800! @berrynat02 @prestonperrinmd @ameykulkarnimd
0
0
18
#ICYMI: Structural Heart, the official journal of @crfheart, is indexed in PubMed Central! Researchers and institutions worldwide can now access and read articles. https://t.co/BmOacVFZ4i
#CardioTwitter #TVT2023 @ELS_Cardiology @jgranadacrf @MariaAlu3 @gb_mackensen @BGalperMD
0
4
10
A new study authored by @BGalperMD shows transcatheter aortic valve replacement (TAVR) procedures greatly improve patients' quality of life. "The median hospital stay was two days for TAVR and six days for open-heart surgery," says Dr. Galper. Learn more: https://t.co/5KJaoQB2M8
0
1
2
#TVT2023 kicks off with two focused & interactive programs. Don't miss out on the chance to engage with & learn from esteemed experts! https://t.co/fvg2iJAcNO ✨Structural Heart Disease #Imaging: Anatomy, Guidance, & Technical Outcomes ✨iCOACH EC: A Practical Tutorial for
0
12
27
Excellent session on vascular closure & complication bailout methods. Broad range of discussion from transfemoral/transaxillary access to equipment to familiarize oneself with should a complication arise. @crfheart @TCTMD @TCTConference @RajTayalMD @BGalperMD @DrVivianNg #tvt2023
0
5
12
Excited for TVT 2023 to get underway. iCOACH EC this morning great opportunity for fellows and EC to engage in key aspects to ensure procedural success. Looking forward to speaking with @DrVivianNg @RajTayalMD on femoral access in TAVR. Should be a great meeting! @crfheart
0
5
14
So excited for this big moment for @crfshj even more reason for you to submit your exciting research to the premier structural heart disease journal. It is such an honor to serve as an associate editor and to work with such an amazing group of editors!
Structural Heart, the official journal of @crfheart, is indexed in PubMed Central! Researchers and institutions worldwide can now access and read articles. https://t.co/BmOacVFZ4i
#CardioTwitter #TVT2023 @ELS_Cardiology @jgranadacrf @MariaAlu3 @gb_mackensen @BGalperMD
0
2
15
#ICYMI: Cost-effectiveness of TAVR in Low-Risk Patients @howard_herrmann @tavrkapadia @bgalperMD @djc795 #AHAJournals
#OriginalResearch: Transfemoral #TAVR compared with #SAVR - cost savings at 2 years in patients with Low Surgical Risk #AorticStenosis - Data from PARTNER 3 @howard_herrmann @tavrkapadia @bgalperMD @djc795 #AHAJournals
https://t.co/Jza5Wph9w6
1
5
7
Dr. David Cohen’s Top 10 high yield Interventional Cardiology trials. Published years ago, but still very relevant and laid the foundation of what we do today. #Fellows2023 @crfheart
3
6
21